Informação do artigo
O texto completo está disponível em PDF
Referências
[1]
World Health Organization (WHO). Immunization, vaccines and biological. Pertussis [atualizado em 21 Jum 2011; acessado em 13Ago 2013]. Disponível em: http://www.who.int/immunization/topics/pertussis/en/index.html.
[2]
S. Mattoo, J.D. Cherry.
Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies.
Clin Microbiol Rev., 18 (2005), pp. 326-382
[3]
Y. Sato, H. Sato.
Development of acellular pertussis vaccines.
Biologicals., 27 (1999), pp. 61-69
[4]
J.D. Cherry.
Epidemic pertussis in 2012 – the resurgence of a vaccine-preventable disease.
N Engl J Med., 367 (2012), pp. 785-787
[5]
U. Heininger.
Pertussis immunisation in adolescents and adults.
Adv Exp Med Biol., 609 (2008), pp. 72-97
[6]
M. Korppi.
Mixed microbial aetiology of community-acquired pneumonia in children.
APMIS., 110 (2002), pp. 515-522
[7]
W.L. Nelson, R.S. Hopkins, M.H. Roe, M.P. Glode.
Simultaneous infection with Bordetella pertussis and respiratory syncytial virus in hospitalized children.
Pediatr Infect Dis., 5 (1986), pp. 540-544
[8]
M. Korppi, J. Hiltunen.
Pertussis is common in nonvaccinated infants hospitalized for respiratory syncytial virus infection.
Pediatr Infect Dis J., 26 (2007), pp. 316-318
[9]
K. Nuolivirta, P. Koponen, Q. He, A. Halkosalo, M. Korppi, T. Vesikari, et al.
Bordetella pertussis infection is common in nonvaccinated infants admitted for bronchiolitis.
Pediatr Infect Dis J., 29 (2010), pp. 1013-1015
[10]
A.E. Ferronato, A.E. Gilio, S.E. Vieira.
Respiratory viral infections in infants with clinically suspected pertussis.
J Pediatr (Rio J)., 89 (2013), pp. 549-553
[11]
H. Guinto-Ocampo, J.E. Bennett, M.W. Attia.
Predicting pertussis in infants.
Pediatr Emerg Care., 24 (2008), pp. 16-20
[12]
N.S. Crowcroft, R. Booy, T. Harrison, L. Spicer, J. Britto, Q. Mok, et al.
Severe and unrecognised: pertussis in UK infants.
Arch Dis Child., 88 (2003), pp. 802-806
[13]
C. Cosnes-Lambe, J. Raymond, M. Chalumeau, C. Pons-Catalano, F. Moulin, N. de Suremain, et al.
Pertussis and respiratory syncytial virus infections.
Eur J Pediatr., 167 (2008), pp. 1017-1019
[14]
D. Greenberg, E. Bamberger, S. Ben-Shimol, R. Gershtein, D. Golan, I. Srugo.
Pertussis is under diagnosed in infants hospitalized with lower respiratory tract infection in the pediatric intensive care unit.
Med Sci Monit., 13 (2007), pp. CR475-CR480
[15]
S. Altunaiji, R. Kukuruzovic, N. Curtis, J. Massie.
Antibiotics for whooping cough (pertussis).
Cochrane Database Syst Rev., (2007), pp. CD004404
[16]
G. De Serres, N. Boulianne, B. Duval.
Field effectiveness of erythromycin prophylaxis to prevent pertussis within families.
Pediatr Infect Dis J., 14 (1995), pp. 969-975
[17]
S.A. Halperin, R. Bortolussi, J.M. Langley, B.J. Eastwood, G. De Serres.
A randomized, placebo-controlled trial of erythromycin estolate chemoprophylaxis for household contacts of children with culture-positive bordetella pertussis infection.
Pediatrics., 104 (1999), pp. e42
[18]
J.D. Cherry.
Pertussis: challenges today and for the future.
PLoS Pathog., 9 (2013), pp. e1003418
[19]
F. Zepp, U. Heininger, J. Mertsola, E. Bernatowska, N. Guiso, J. Roord, et al.
Rationale for pertussis booster vaccination throughout life in Europe.
Lancet Infect Dis., 11 (2011), pp. 557-570
Ferramentas
Publicar em
Jornal de Pediatria
Edição nº 1
Faça o download da edição nº1 do Jornal de Pediatria, de 1934
Ano
1934
Jornal do Pediatria nº1
